Outcomes of orthotopic heart transplantation and left ventricular assist device in patients aged 65 years or more with end-stage heart failure

Age has traditionally been a limiting factor for advanced heart failure (HF) therapies. Orthotopic heart transplantation (OHT) age guidelines have become less restrictive, and left ventricular assist devices (LVADs) are increasingly utilized as destination therapy for patients ≥65 years. Although in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc (Bayl Univ Med Cent)
Main Authors: Harmon, David M., Tecson, Kristen M., Jamil, Aayla K., Felius, Joost, Gonzalez-Stawinski, Gonzalo V., Joseph, Susan M., Hall, Shelley A.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6541055/
https://ncbi.nlm.nih.gov/pubmed/31191122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2019.1576095
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados